doi: 10.1002/epi4.12740.
- PMID: 37042946
- DOI: 10.1002/epi4.12740
Free article
Abstract
Febrile infection-related epilepsy syndrome (FIRES) is a prolonged refractory status epilepticus (SE) that develops among healthy individuals after a febrile infection. FIRES treatment is challenging due to its poor response to antiseizure medications (ASMs) and anesthetic drugs. The use of cannabidiol (CBD) as an adjunctive treatment has been suggested, albeit data about its role in the acute phase is lacking. This report describes the use of purified CBD in the acute phase of two pediatric cases of FIRES and their long-term outcome. Both children were treated with several ASMs, immunomodulators, anesthetics, and nonpharmacological treatment (ketogenic diet). CBD was administered, as an adjunctive treatment, through nasogastric tube about 30 days after onset. SE resolved within 3 days of reaching the target dose and both were seizure-free for 1 year after. Although it is difficult to define the extent to which each previous therapy contributed to recovery, in both cases CBD therapy was a turning point, reinforcing its potential role as add-on treatment in the acute phase of FIRES.
Keywords: CBD, cytokine, neuroinflammation, status epilepticus
© 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Similar articles
-
Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?Brain Dev. 2023 May;45(5):293-299. doi: 10.1016/j.braindev.2023.01.004. Epub 2023 Jan 30.PMID: 36725381
-
Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):128-135. doi: 10.2174/1872213X12666180508122450.PMID: 29745347 Review.
-
Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study.Neurodiagn J. 2017;57(3):224-233. doi: 10.1080/21646821.2017.1355181.PMID: 28898171 Review.
-
Ketogenic diet (KD) therapy in the acute phase of febrile infection-related epilepsy syndrome (FIRES): a case report.Transl Pediatr. 2021 Sep;10(9):2392-2397. doi: 10.21037/tp-21-121.PMID: 34733679 Free PMC article.
-
Ketogenic Diet for a Young Adult Patient With Chronic-Phase Febrile Infection-Related Epilepsy Syndrome.Cureus. 2022 Feb 10;14(2):e22099. doi: 10.7759/cureus.22099. eCollection 2022 Feb.PMID: 35165646 Free PMC article.
References
REFERENCES
-
- Kramer U, Chi CS, Lin KL, Specchio N, Sahin M, Olson H, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52(11):1956-65.
-
- Gaspard N, Hirsch LJ, Sculier C, Loddenkemper T, van Baalen A, Lancrenon J, et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia. 2018;59(4):745-52. Available from:[cited 2022]. https://doi.org/10.1111/epi.14022
-
- Specchio N, Pietrafusa N. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Dev Med Child Neurol. 2020;62(8):897-905. Available from:[Internet] [cited 2022].
-
- Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739-44. Available from: [cited 2022].
-
- Koh S, Wirrell E, Vezzani A, Nabbout R, Muscal E, Kaliakatsos M, et al. Proposal to optimize evaluation and treatment of febrile infection-related epilepsy syndrome (FIRES): a report from FIRES workshop. Epilepsia. 2021;6(1):62-72. https://doi.org/10.1002/epi4.12447
